Clinical Trial: A Study to Evaluate the Long-term Safety of HS-10380 in Patients With Schizophrenia

U.S., Aug. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07759869) titled 'A Study to Evaluate the Long-term Safety of HS-10380 in Patients With Schizophrenia' on Aug. 07.

Brief Summary: The primary purpose of this open-label phase 3 study is to evaluate the safety of HS-10380 on the incidence, severity, relationship to investigational product of adverse events (AE), serious adverse events (SAE), and adverse events leading to study drug discontinuationin Chinese adult participants with schizophrenia.

Study Start Date: Sept. 09

Study Type: INTERVENTIONAL

Condition: SCHIZOPHRENIA 1 (Disorder)

Intervention: DRUG: HS-10380

Oral;QD;W1:dose titration; W1-2:dose adjust to optimal level;Week 3-52:stable dos...